SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 164.45%105.31K | 54.53%-379.67K | 13.56%-1.18M | -191.56%-3.6M | -304.90%-1.24M | 65.81%-163.39K | -74.59%-835K | -5,091.75%-1.36M | 67.72%-1.23M | -61,987.80%-305.47K |
Net income from continuing operations | 106.55%58.96K | 134.09%30.2K | -10.33%-1.31M | -18.14%-3.4M | -73.85%-1.23M | -37.91%-900.78K | 89.73%-88.59K | -80.06%-1.19M | 35.07%-2.88M | 57.52%-705.05K |
Depreciation and amortization | -18.03%109.24K | -10.78%115.88K | -8.47%117.25K | 5.44%523.99K | 9.86%132.74K | 9.27%133.26K | 6.40%129.89K | -3.02%128.11K | 0.62%496.95K | 1.71%120.83K |
Other non cash items | --15.62K | --60.62K | -69.37%15.62K | 195.21%160.41K | --109.41K | --0 | --0 | -6.14%51K | -76.17%54.34K | --0 |
Change In working capital | -163.01%-301.88K | 19.62%-603.93K | 118.58%95.44K | -348.81%-860.03K | 57.02%-74.06K | 797.84%479.13K | -386.72%-751.3K | -353.61%-513.8K | 134.50%345.66K | -129.02%-172.34K |
-Change in receivables | -66.81%294.1K | -86.18%-1.42M | 45.87%410.86K | 143.47%319.82K | 80.56%-84.47K | 320.56%886.11K | -235.31%-763.46K | 160.72%281.65K | -272.33%-735.81K | -184.49%-434.43K |
-Change in inventory | -333.50%-298.5K | 714.00%364.27K | -113.18%-18.78K | -186.09%-131.1K | -219.27%-145.46K | -196.01%-68.86K | -118.81%-59.33K | 139.95%142.54K | 115.83%152.28K | 171.47%121.95K |
-Change in prepaid assets | 28.10%-26.95K | -78.72%92.05K | -17.47%-107.8K | 313.91%434.78K | 3,162.47%131.53K | 76.34%-37.48K | 340.56%432.5K | 33.85%-91.77K | -214.28%-203.25K | -103.76%-4.3K |
-Change in payables and accrued expense | -65.24%-137.59K | 105.62%403.67K | 82.52%-118.88K | -170.99%-547.93K | -97.19%19.22K | -206.31%-83.26K | 130.76%196.33K | -204.87%-680.21K | 374.87%771.81K | 1,185.83%683.14K |
-Change in other current assets | -11.59%-34.17K | 0.88%-44.46K | 5.11%-43.25K | 57.42%-75.57K | 202.87%45.49K | 32.53%-30.62K | -17.05%-44.86K | 8.00%-45.58K | -77.21%-177.47K | -146.34%-44.22K |
-Change in other current liabilities | -3.00%-41.58K | -3.00%-41.58K | -3.00%-40.37K | -3.00%-160.29K | -3.00%-40.37K | -3.01%-40.37K | -3.00%-40.37K | -3.00%-39.19K | -3.00%-155.62K | -3.01%-39.19K |
-Change in other working capital | ---- | 109.22%43.53K | 116.81%13.66K | -200.86%-699.73K | --0 | -126.71%-146.38K | ---472.11K | -113.52%-81.24K | 714.57%693.73K | -514.78%-455.29K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 164.45%105.31K | 54.53%-379.67K | 13.56%-1.18M | -191.56%-3.6M | -304.90%-1.24M | 65.81%-163.39K | -74.59%-835K | -5,091.93%-1.36M | 67.72%-1.23M | -61,861.87%-305.47K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -5.38K | 92.63%-4.44K | -178.24%-94.84K | 10.25%-216.69K | 25.04%-122.4K | 0 | -16.23%-60.21K | -138.68%-34.09K | 62.24%-241.45K | 52.65%-163.28K |
Capital expenditure reported | ---- | ---- | ---- | -192.41%-118.63K | ---- | ---- | ---- | ---- | 67.98%-40.57K | 67.72%-26.11K |
Net PPE purchase and sale | ---5.38K | 92.63%-4.44K | -178.24%-94.84K | 51.18%-98.06K | 97.26%-3.77K | --0 | -61.24%-60.21K | -138.68%-34.09K | 60.82%-200.88K | 48.03%-137.17K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---5.38K | 92.63%-4.44K | -178.24%-94.84K | 10.25%-216.69K | 25.04%-122.4K | --0 | -16.23%-60.21K | -138.68%-34.09K | 62.24%-241.45K | 52.65%-163.28K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | 27.5K | 9,050.40%2.29M | 2.29M | 0 | 0 | 0 | -99.45%25K | 0 |
Net issuance payments of debt | ---- | ---- | ---- | --2.29M | ---- | ---- | ---- | ---- | --0 | ---- |
Proceeds from stock option exercised by employees | --0 | --0 | --27.5K | --0 | --0 | --0 | --0 | --0 | -99.45%25K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | --0 | --27.5K | 9,050.40%2.29M | --2.29M | --0 | --0 | --0 | -99.45%25K | --0 |
Net cash flow | ||||||||||
Beginning cash position | -54.95%709.11K | -55.73%1.09M | -39.51%2.34M | -27.28%3.87M | -67.46%1.41M | -67.21%1.57M | -53.68%2.47M | -27.28%3.87M | 2.28%5.32M | -23.44%4.34M |
Current changes in cash | 161.16%99.93K | 57.09%-384.11K | 10.85%-1.25M | -5.31%-1.53M | 298.05%928.36K | 64.86%-163.39K | -68.89%-895.21K | -10,824.74%-1.4M | -1,323.19%-1.45M | -35.75%-468.75K |
End cash Position | -42.65%809.04K | -54.95%709.11K | -55.73%1.09M | -39.51%2.34M | -39.51%2.34M | -67.46%1.41M | -67.21%1.57M | -53.68%2.47M | -27.28%3.87M | -27.28%3.87M |
Free cash flow | 161.16%99.93K | 57.09%-384.11K | 8.88%-1.27M | -158.54%-3.82M | -189.97%-1.36M | 66.65%-163.39K | -68.89%-895.21K | -10,824.74%-1.4M | 66.93%-1.48M | -35.75%-468.75K |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |